Subscribe
The latest psychology and neuroscience discoveries.
My Account
  • Mental Health
  • Social Psychology
  • Cognitive Science
  • Psychopharmacology
No Result
View All Result
PsyPost
PsyPost
No Result
View All Result
Home Exclusive Psychopharmacology Psychedelic Drugs Microdosing

Psilocybin microdosers display mental health improvement during 1 month period compared to non-microdosers

by Patricia Y. Sanchez
July 22, 2022
in Microdosing, Psilocybin, Psychedelic Drugs

[Subscribe to PsyPost Premium to enjoy an ad-free experience! Click here to sign up.]

Share on FacebookShare on Twitter

Psilocybin, the active compound in “magic mushrooms,” has been shown to be a promising treatment for various mental health issues. New research published in Scientific Reports found that people who microdose psychedelics displayed greater improvements in mental health and mood over the span of 1 month compared to non-microdosers.

Most of the research on psilocybin treatment has focused on doses that are large enough to contribute to a substantial alteration of one’s consciousness. However, “microdosing,”or taking a small enough dose of psilocybin to not impair cognitive functioning, has become increasingly popular.

“Improvements in mood, emotional well-being and cognition have been reported among the top motivations for microdosing, and several cross-sectional studies have identified associations between microdosing and perceived improvements in mood and cognitive functioning, reductions in stress, depression, and anxiety,” wrote study author Joseph M. Rootman and colleagues.

Relatively fewer studies have investigated the effects of microdosing and these studies have not included a non-microdosing control group, which is essential in evaluating any causal effects of microdosing. To address this gap, researchers collected data from respondents participating in a larger study of psychedelic microdosing.

“The study consisted of a baseline assessment completed at the study outset, and a follow-up assessment completed 22–35 days later; the assessment schedules were equivalent for both microdosers and non-microdosers. The assessments queried past month psychedelic practices, mood and mental health, and presented tasks testing cognitive and psychomotor processing.”

Each assessment lasted 20-30 minutes.

Results show that microdosers were more likely to be older, White, and employed full-time compared to non-microdosers. All other demographic variables did not differ between microdosers and non-microdosers. Results also show that microdosers displayed greater improvements from baseline after 1 month on depression, anxiety, and stress scores compared to non-microdosers.

Similarly, microdosers showed greater increases in positive mood and larger decreases in negative mood over the duration of the study compared to non-microdosers. Microdosers demonstrated more positive change in psychomotor performance compared to non-microdosers. There were no differences in spatial memory or processing speed between the two dosage groups.

Overall, these results are generally consistent with previous research demonstrating the positive mental health benefits of psilocybin use, both in large and small doses.

“Notably, the subgroup of respondents who reported mental health concerns at the time of baseline assessment exhibited an average reduction in depressive symptoms that resulted in a change from moderate to mild depression following approximately 30 days of microdosing psychedelics. Considering the tremendous health costs and ubiquity of depression, as well as the sizable proportion of patients who do not respond to extant treatments, the potential for another approach to addressing this deadly disorder warrants substantial consideration.”

The authors cite some limitations to their work including the small sample size, the observational nature of the data, and self-selection recruitment strategy. Perhaps recruiting via venues that are favorable to psychedelic use influenced the type of participant who would sign up for this study.

The study, “Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controls“, was authored by Joseph M. Rootman, Maggie Kiraga, Pamela Kryskow, Kalin Harvey, Paul Stamets, Eesmyal Santos-Brault, Kim P. C. Kuypers, and Zach Walsh.

ShareTweetSendScanShareSharePin17Send
Previous Post

Large systematic review finds no evidence for the serotonin hypothesis of depression

Next Post

Friends tend to agree on their best — but not their worst — personality traits

STAY CONNECTED

Find these awesome psychology shirts and more at the PsyPost Store!

TRENDING

New study identifies perceived mattering as a core psychological component of happy marriages

Engaging in LGBQ activism is associated with positive psychological functioning among sexual minorities

People with social anxiety more likely to become overdependent on conversational artificial intelligence agents

Breathing exercises show potential in modulating Alzheimer’s biomarkers, study finds

New psychology research reveals the “bullshit blind spot”

Diversity of the gut microbiota is associated with the severity of depression

RECENT

New study on orienteering suggests cognitive flexibility can be developed through sports training

Contrary to prior research, Brazilian study finds economic scarcity is not linked to racial perception

Individuals prompted to experience gratitude and indebtedness are more likely to behave in prosocial ways

Engaging in LGBQ activism is associated with positive psychological functioning among sexual minorities

Vegans are perceived as less suitable for jobs stereotypically associated with masculinity, study finds

People with social anxiety more likely to become overdependent on conversational artificial intelligence agents

New study highlights several key predictors of gratitude to God

Women show higher levels of intrasexual competition than men

Currently Playing

New psychology research reveals the “bullshit blind spot”

New psychology research reveals the “bullshit blind spot”

New psychology research reveals the “bullshit blind spot”

Cognitive Science
Higher prenatal testosterone exposure is linked to Machiavellianism and psychopathy, study suggests

Higher prenatal testosterone exposure is linked to Machiavellianism and psychopathy, study suggests

Dark Triad
New study identifies perceived mattering as a core psychological component of happy marriages

New study identifies perceived mattering as a core psychological component of happy marriages

Relationships and Sexual Health
Childhood adversity associated with increased emotional response to others’ suffering in adulthood

Childhood adversity associated with increased emotional response to others’ suffering in adulthood

Mental Health
New study sheds light on cognitive mechanisms linked to hypnosis

Chronic intake of refined carbohydrates between meals is associated with decreased cognitive performance, study finds

Cognitive Science
Mindfulness might hinder prosocial behavior among individuals with high intelligence

Mindfulness might hinder prosocial behavior among individuals with high intelligence

Social Psychology
  • Cognitive Science
  • COVID-19
  • Mental Health
  • Social Psychology
  • Drug Research
  • Conspiracy Theories
  • Meditation
  • Psychology of Religion
  • Aviation Psychology and Human Factors
  • Relationships and Sexual Health
  • Evolutionary Psychology
  • Neuroimaging
  • Psychedelic Drugs
  • Dark Triad
  • Political Psychology

About

PsyPost is a psychology and neuroscience news website dedicated to reporting the latest research on human behavior, cognition, and society. (READ MORE...)

  • Contact us
  • Privacy policy

Subscribe
  • My Account
  • Cognitive Science Research
  • Mental Health Research
  • Social Psychology Research
  • Drug Research
  • Relationship Research
  • About PsyPost
  • Contact
  • Privacy Policy

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

This website uses cookies. By continuing to use this website you are giving consent to cookies being used.